Medtronic sees $8B in Q2 sales for fiscal year 2024

Spinal Tech

Medtronic on Nov. 21 posted its financial results for the second quarter of the fiscal year 2024.

Four things to know:

1. The company saw a 5.3% revenue increase year-over-year with $8 billion.

2. Medtronic's neuroscience portfolio saw a 4.7% year-over-year increase with $2.28 billion.

3. The cranial and spinal technologies segment saw a 7% increase year-over-year with $1.2 billion.

4. Medtronic raised its revenue growth guidance to 4.75%.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers